Companies: 10,795·Total market cap: $144.5T

Prothena Corporation plc

Prothena Corporation plc

PRTANASDAQHealthcare● Active

$8.56

$-0.23(-2.62%)

Market Cap$448143709

P/E Ratio—

52W High$11.8

52W Low$4.95

Avg Volume521K

Open$8.80

Beta-0.32

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Prothena Corporation plc（PRTA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PRTA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-2.81Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$57.9MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding53.8MShares outstanding history

Next EarningsAug 3, 2026Est.Earnings history

探索 Prothena Corporation plc 数据

分析师预测$19 · Buy

股息不分红

营收$9.7M-92.83%

盈利EPS $-4.53-99.56%

财务快照

FY 2025Revenue$9.7M▼ 92.83% YoY

202320242025

FY 2025Net Income-$244.1M▼ 99.57% YoY

202320242025

FY 2025EPS$-4.53▼ 99.56% YoY

202320242025

TTM:Revenue: $57.9MNet Income: -$151.2MEPS: $-2.81View income statement →

分析师评级与目标价

Buy28 位分析师

Strong Buy

0

Buy

20

Hold

6

Sell

2

Strong Sell

0

12-Month Price Target

$19.00Low

$8.56Current

$19.00Avg Target上涨空间 121.96%

$19.00High

合计: 28 · 买入占比: 71.4%

根据过去 3 个月内 28 位华尔街分析师，PRTA 共识评级为 Buy，12 个月平均目标价 $19.00 （较现价 $8.56 上涨空间 121.96%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Prothena Corporation plc

$8.56-2.62%$448.1M #2

Bicycle Therapeutics plc

$4.11-2.14%$285.2M #3

Corvus Pharmaceuticals, Inc.

$11.15+0.27%$937.6M #4

4D Molecular Therapeutics, Inc.

$8.64+0.00%$451.7M #5

Gossamer Bio, Inc.

$0.17-5.37%$38.9M #6

KalVista Pharmaceuticals, Inc.

$26.99+0.15%$1.4B

股票表现

1D-2.62%

1W-7.06%

1M-20.22%

3M-10.74%

YTD-10.37%

1Y+63.05%

5Y-78.29%

关于 Prothena Corporation plc

CEOGene G. Kinney

IPO DateDec 18, 2012

Employees163

CountryUS

Websiteprothena.com

Prothena Corporation plc Established in 2012 and headquartered in Dublin, Ireland, Prothena Corporation plc functions as a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapeutic…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Prothena Corporation plc（PRTA）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 18, 2012 在 NASDAQ 上市。截至最近交易日，PRTA 股价为 $8.56，市值约为 $448.1M。过去12个月累计回报 +63.05%，年初至今回报 -10.37%。

根据 28 位华尔街分析师，Prothena Corporation plc 股票共识评级为Buy，12个月平均目标价为 $19.00。2025 财年 Prothena Corporation plc 营收 $9.7M，净利润 -$244.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Prothena Corporation plc（PRTA）股价为 $8.56，在 NASDAQ 上市，52周区间为 $4.95 – $11.80。

PRTA 最新股价PRTA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议